Successful Commissioning Of A New Pharmaceutical-Grade Guanidine Hydrochloride Production Line in Lanzhou New Area, Gansu
Dec 12, 2023| Successful Launch of New Production Line for Pharmaceutical-Grade Guanidine Hydrochloride in Lanzhou, Gansu Province
Date: December 10, 2023
Lanzhou, December 10, 2023 - The pharmaceutical production facility in Gansu Lanzhou's new district is excited to announce the official commencement of operations for its new production line. After years of dedicated effort and technological innovation, this milestone marks a significant breakthrough for the company in the field of pharmaceutical-grade guanidine hydrochloride, providing the market with higher-quality products.
The newly commissioned production line is designed with an annual production capacity of 3000 tons of pharmaceutical-grade guanidine hydrochloride, highlighting a substantial increase in the company's production capabilities. Through the latest technological upgrades, the new production line not only enhances output but also significantly improves product quality.
Accumulating years of experience, the company has consistently focused on the research and production of pharmaceutical-grade guanidine hydrochloride, continuously driving technological innovation. The launch of the new production line is another crucial milestone, solidifying the company's leading position in the pharmaceutical manufacturing sector.
The upgrades implemented in the new production line not only increase production capacity but also emphasize the optimization of product quality. By adopting the latest production technologies and quality management systems, the company ensures that the pharmaceutical-grade guanidine hydrochloride produced meets the highest industry standards. This upgrade aims to provide customers with more reliable and high-quality pharmaceutical raw materials to meet the growing demands of the market.
The Chairman of the company stated, "The commissioning of the new production line is the result of our relentless efforts and investment, reaffirming our commitment to excellence in the field of pharmaceutical-grade guanidine hydrochloride. We will continue to focus on technological innovation and quality management to enhance our product competitiveness and provide exceptional service to our customers."
The launch of the new production line signifies a significant step forward for the company in the pharmaceutical industry. Upholding the philosophy of "Quality First, Innovation Leading," we are committed to providing customers with outstanding products and services, contributing to the sustainable development of the industry.